Nicox S.A. (EPA: ALCOX)
France
· Delayed Price · Currency is EUR
0.302
0.00 (0.00%)
Jan 17, 2025, 5:35 PM CET
Nicox Revenue
Nicox had revenue of 1.73M EUR in the half year ending June 30, 2023, with 31.09% growth. This brings the company's revenue in the last twelve months to 3.57M, down -51.31% year-over-year. In the year 2022, Nicox had annual revenue of 3.27M, down -54.78%.
Revenue (ttm)
3.57M
Revenue Growth
-51.31%
P/S Ratio
4.00
Revenue / Employee
127.64K
Employees
28
Market Cap
20.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 3.27M | -3.96M | -54.78% |
Dec 31, 2021 | 7.23M | -5.67M | -43.96% |
Dec 31, 2020 | 12.91M | 6.05M | 88.29% |
Dec 31, 2019 | 6.86M | 2.83M | 70.23% |
Dec 31, 2018 | 4.03M | 1.72M | 74.71% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech | 2.74B |
bioMérieux | 3.81B |
Ipsen | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac | 1.34B |
Ramsay Générale de Santé | 5.01B |